New York A 3426: Enacts Gio's Law requiring that members of all emergency service providers be trained in the administration of emergency anaphylaxis treatment and to carry emergency anaphylaxis treatment in their vehicles

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A03426 Summary:

BILL NOA03426 

&nbsp

SAME ASSAME AS S06851

&nbsp

SPONSORMcDonald (MS)

&nbsp

COSPNSRBenedetto, Seawright, Steck, Lupardo, Jones, Colton, Ra, Sayegh, Morinello, Buttenschon, Ramos,
 Bronson, Simone, Dinowitz

&nbsp

MLTSPNSRHawley, Tague

&nbsp

Add Art 29-H §2999-ff, Pub Health L; add §6801-b, Ed L; amd §5, Chap 21 of 2011

&nbsp

Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients; makes permanent certain provisions relating to authorizing pharmacists to perform with physicians in certain settings.

Go to top A03426 Actions:

BILL NOA03426 

&nbsp

01/27/2025referred to higher education

01/07/2026referred to higher education

Go to topA03426 Committee&nbspVotes:

Go to topA03426 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA03426 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 3426

 2025-2026 Regular Sessions

 IN ASSEMBLY

 January 27, 2025
 ___________

 Introduced by M. of A. McDONALD, BENEDETTO, SEAWRIGHT, STECK, LUPARDO,
 JONES, COLTON, RA, SAYEGH, MORINELLO, BUTTENSCHON, RAMOS, BRONSON,
 SIMONE -- Multi-Sponsored by -- M. of A. HAWLEY, TAGUE -- read once
 and referred to the Committee on Higher Education

 AN ACT to amend the public health law and the education law, in relation
 to collaborative practice medication adherence; and to amend chapter
 21 of the laws of 2011 amending the education law relating to author-
 izing pharmacists to perform collaborative drug therapy management
 with physicians in certain settings, in relation to making the
 provisions of such chapter permanent

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. This act shall be known and may be cited as the "Collabora-
 2 tive Practice Medication Adherence Act".
 3 § 2. The public health law is amended by adding a new article 29-H to
 4 read as follows:
 5 ARTICLE 29-H
 6 COLLABORATIVE PRACTICE MEDICATION ADHERENCE ACT
 7 Section 2999-ff. Collaborative practice medication adherence.
 8 § 2999-ff. Collaborative practice medication adherence. 1. Defi-
 9 nitions. As used in this article, the following terms shall have the
 10 following meanings:
 11 (a) Qualified pharmacist. The term "qualified pharmacist" shall mean a
 12 pharmacist who maintains a current unrestricted license pursuant to
 13 article one hundred thirty-seven of the education law, who has a minimum
 14 of two years of experience in patient care as a practicing pharmacist
 15 within the last five years, and who has demonstrated competency in medi-
 16 cation adherence of patients with a chronic disease or diseases, includ-
 17 ing, but not limited to, the completion of one or more programs which
 18 are accredited by the accreditation council for pharmacy education,

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD05735-01-5

 A. 3426 2

 1 recognized by the education department and acceptable to the patient's
 2 treating physician.
 3 (b) Patient care. The term "patient care" shall mean assessing the
 4 appropriateness of prescription and non-prescription drugs for individ-
 5 ual patients based on an assessment of the patient's medication history,
 6 medication experience including beliefs, concerns, understanding and
 7 expectations, the clinical goals of therapy, potential drug-to-drug
 8 interactions or other medication safety concerns, recommendations for
 9 adherence and consulting with a patient or caregiver.
 10 (c) Collaborative practice medication adherence. The term "collabora-
 11 tive practice medication adherence" shall mean a program conducted by a
 12 qualified pharmacist that ensures a patient's medications, whether
 13 prescription or nonprescription, are individually assessed to determine
 14 that each medication is appropriate for the patient, effective for the
 15 medical condition, safe given the comorbidities and other medications
 16 being taken, and able to be taken by the patient as intended. Collabora-
 17 tive practice medication adherence protocols conducted by a qualified
 18 pharmacist shall include sharing of applicable patient clinical informa-
 19 tion wit